$9.51
-0.06 (-0.63%)
Open$9.49
Previous Close$9.57
Day High$9.66
Day Low$9.24
52W High$55.89
52W Low$5.20
Volume—
Avg Volume302.0K
Market Cap140.92M
P/E Ratio—
EPS$-10.00
SectorBiotechnology
Analyst Ratings
Strong Buy
18 analysts
Price Target
-57.5% upside
Current
$9.51
$9.51
Target
$4.04
$4.04
$2.50
$4.04 avg
$4.74
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 10.02M | 13.03M | 16.40M |
| Net Income | -183,784,881 | -215,148,794 | -3,544,265 |
| Profit Margin | -1,834.5% | -1,742.8% | -21.6% |
| EBITDA | -184,278,190 | -227,711,082 | -3,398,004 |
| Free Cash Flow | — | — | -3,167,900 |
| Rev Growth | -23.1% | -23.1% | +19.8% |
| Debt/Equity | — | — | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |